Resources

Empagliflozin shows improvements in key diabetes parameters as well as weight reduction….

Study shows a higher ratio of high-calorie foods to low-calorie foods were purchased between 4pm and 7pm compared to 1pm and 4pm….

The perception that insulin therapy may be too burdensome for patients has led primary care physicians to delay the use of insulin therapy in patient with type 2 diabetes….

New mouse model shows how type 2 diabetes might develop….

Study shows peaks and clusters of type 1 diabetes, paralleling viral patterns….

Nano-particle network maintains normal blood glucose levels for up to 10 days….

Mediterranean diet may delay the onset of symptoms of dementia….

An inflammatory protein, calprotectin, links hyperglycemia to myelopoiesis and the increase risk of coronary heart disease….

Elevated levels of a hormone released from adipose tissue may be the key link in the development of type 2 diabetes in obese patients….

Recently, I was chatting electronically with Irl B. Hirsch, MD, Diabetes Treatment and Teaching Chair at the University of Washington School of Medicine. I asked him if he had been using Invokana with his patients, and he sent me back this message: “No, not yet, and not likely to anytime soon …